Daiwa Securities Group Inc. - REVOLUTION MEDICINES INC ownership

REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 126 filers reported holding REVOLUTION MEDICINES INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 1.4%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of REVOLUTION MEDICINES INC
ValueSharesWeighting
Q3 2023$100.0%3570.0%0.00%
Q2 2023$10
+25.0%
3570.0%0.00%
Q1 2023$8
-11.1%
3570.0%0.00%
Q4 2022$9
-99.8%
357
+28.9%
0.00%
Q3 2022$5,0000.0%2770.0%0.00%
Q2 2022$5,0000.0%277
+28.8%
0.00%
Q1 2022$5,0000.0%2150.0%0.00%
Q4 2021$5,000
-28.6%
215
-14.7%
0.00%
Q3 2021$7,000
+40.0%
252
+76.2%
0.00%
Q2 2021$5,000
-28.6%
1430.0%0.00%
Q1 2021$7,000
+40.0%
143
+14.4%
0.00%
Q4 2020$5,0001250.00%
Other shareholders
REVOLUTION MEDICINES INC shareholders Q1 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 5,104,130$99,479,00040.69%
Ponoi II Management, LLC 685,011$13,351,00036.28%
Nextech Invest Ltd. 3,939,529$76,781,00025.90%
Ponoi Management, LLC 685,011$13,351,00021.08%
Column Group LLC 4,395,050$85,660,00018.23%
TRV GP IV, LLC 1,419,900$27,674,00018.20%
Boxer Capital, LLC 3,484,264$67,908,0004.30%
Casdin Capital, LLC 2,370,000$46,191,0003.91%
Cormorant Asset Management, LP 1,995,066$38,884,0002.94%
EcoR1 Capital, LLC 4,278,069$83,380,0002.88%
View complete list of REVOLUTION MEDICINES INC shareholders